GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

The first participant was recruited within 103 days, significantly ahead of the government’s target to reduce commercial trial setup times to under 150 days. Being the first country to recruit a ...

With lung conditions the third biggest killer in Northern Ireland, Asthma + Lung UK Northern Ireland is calling for better ...

St. Luke’s Medical Center Global City has established its Inhaler Clinic Service to optimize the care of patients managing pulmonary disorders such as asthma and Chronic Obstructive Pulmonary Disease ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

The toxic haze that blanketed large parts of India in November didn’t just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.

The anti-asthma and COPD segment grew 10 percent year-on-year in November, outpacing historical winter trends and marking its ...

When you think about diseases that affect the lungs, like chronic obstructive pulmonary disease (COPD), there are likely some ...

Bronchitis cases spike in winter due to cold air, pollution and viral infections irritating the bronchial tubes. Health ...

In both adults with and without self-reported COPD, a 6- or 12-week course of cytisinicline helped more daily smokers achieve ...

People who smoke accounts for nearly 80–90% of COPD cases, but other factors like air pollution, exposure to dust and fumes, ...